Zydus Lifesciences Drug Patent Portfolio

Zydus Lifesciences's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Zydus Lifesciences News

Weight-loss medications expected to see price reductions - The Times of India

24 Feb, 2026

Zydus agrees to pay $120 million to Astellas to resolve patent dispute - The Hans India

13 Feb, 2026

Zydus resolves patent conflict over Mirabegron with Astellas for $120 million in the US.

12 Feb, 2026

Zydus Lifesciences settles US patent conflict over bladder medication for $120 million.

12 Feb, 2026

See More